Devyser BRCA NGS is a fast and robust NGS solution designed for the detection of genetic variants in the BRCA1 and BRCA2 genes. It offers comprehensive and uniform coverage of all coding exons and exon/intron junctions of both genes. In addition, it includes the detection of single nucleotide variants (SNVs), insertions/deletions (Indels), and copy number variations (CNVs), in both germline and somatic contexts.

Key Features

Comprehensive variant detection: Identifies relevant genetic variants in the BRCA1 and BRCA2 genes.
Fast workflow: optimized for rapid results with same-day library preparation and less than 45 minutes of hands-on time.
Identification of germline and somatic variants, including CNV detection.
Dedicated software: Provides automated, user-friendly analysis, with options for batch export and efficient variant analysis without the need for bioinformatics expertise.
Devyser BRCA NGS

Clinical Applications

It is intended for the comprehensive screening and characterization of BRCA1 and BRCA2, including SNV and CNV detection.

Intended Audience / User

Ideal for laboratories focused on the comprehensive screening and characterization of the BRCA1 and BRCA2 genes, including the detection of both SNVs and CNVs.

Benefits

Streamlined workflow: easy to implement and suitable for laboratories with varying sample volume needs. Ready-to-use reagents, ensuring a reproducible process and reducing the risk of sample mix-ups or contamination. Intuitive software: facilitates the interpretation of obtained data, reducing the need for bioinformatics intervention.

Technical Specifications

Starting material: Human genomic DNA extracted from whole blood or FFPE tissue.

Ordering Information

CE-IVD Kits
8-A100-8 8 tests
8-A100-24 24 tests
8-A100-96 96 tests
Accessories
8-A204 Devyser Library Clean
8-A200 Devyser Index Plate A

Other references: RUO version with references 8-A102-8, 8-A102-24, and 8-A102-96.

Area:

Hereditary cancer, Molecular Genetics, Solid tumor, Targeted study of specific pathologies

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Devyser LynchFAP

Devyser LynchFAP is a targeted NGS solution for the analysis of germline variants associated with hereditary colorectal cancer syndromes. The assay enables the detection of SNVs, indels, and CNVs in genes related to Lynch syndrome, familial adenomatous polyposis (FAP), and MUTYH-associated polyposis (MAP), also incorporating a specific LR-PCR for the correct localization of variants in…
Devyser
Next Generation Sequencing (NGS)

Devyser HBOC NGS

Devyser HBOC NGS is a fast and robust NGS solution aimed at the detection of germline variants in 12 genes associated with an increased risk of hereditary breast and ovarian cancer: ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53. It offers comprehensive and uniform coverage of all coding exons and exon/intron…
Devyser
Next Generation Sequencing (NGS)

Devyser BRCA PALB2 NGS

Devyser BRCA PALB2 NGS is a fast and robust NGS solution designed for the detection of genetic variants in the BRCA1, BRCA2, and PALB2 genes. It offers comprehensive and uniform coverage of all coding exons and exon/intron junctions of both genes. In addition, it includes the detection of single nucleotide variants (SNVs), insertions/deletions (Indels), and…
Devyser
Next Generation Sequencing (NGS)

Nanotype® Mono

Optimized solution for high-resolution single-sample HLA typing using nanopore sequencing, ideal for environments requiring immediacy and flexibility. Detailed Description Nanotype® Mono is a compact solution from Werfen for high-resolution HLA typing based on nanopore sequencing technology (Oxford Nanopore Technologies), specially designed for the analysis of a single sample per run. It is ideal for laboratories…
Werfen
3rd Generation Sequencing (Long-read)